Dr Wesley Kim, | |
1301 Punchbowl St, 4th Floor, Honolulu, HI 96813-2402 | |
(808) 547-4271 | |
Not Available |
Full Name | Dr Wesley Kim |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 29 Years |
Location | 1301 Punchbowl St, Honolulu, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427005743 | NPI | - | NPPES |
0049123301 | Medicaid | HI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 10901 (Hawaii) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Queens Medical Center | Honolulu, HI | Hospital |
North Hawaii Community Hospital | Kamuela, HI | Hospital |
Kuakini Medical Center | Honolulu, HI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hawaii Pathologists Laboratory | 4880585876 | 17 |
News Archive
Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.
Centene Corporation announced today its new subsidiary, IlliniCare Health Plan, was selected by the Illinois Department of Healthcare and Family Services (HFS) as one of one of two vendors to provide managed care services to approximately 40,000 Older Adults and Adults with Disabilities in six Chicago area counties.
A new study appearing in the Journal of Bone and Joint Surgery (JBJS) links the use of opioid pain relievers (prescription medications, such as Percocet) to less improvement and higher levels of dissatisfaction following spine surgery.
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
ADVENTRX Pharmaceuticals, Inc. today announced that it will meet the U.S. Food and Drug Administration in Washington D.C. during the last week of April 2010 to review the Company's New Drug Application for ANX-530 (vinorelbine injectable emulsion) and the FDA's refusal-to-file letter.
› Verified 5 days ago
Entity Name | Hawaii Pathologists Laboratory |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114915204 PECOS PAC ID: 4880585876 Enrollment ID: O20040320000708 |
News Archive
Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.
Centene Corporation announced today its new subsidiary, IlliniCare Health Plan, was selected by the Illinois Department of Healthcare and Family Services (HFS) as one of one of two vendors to provide managed care services to approximately 40,000 Older Adults and Adults with Disabilities in six Chicago area counties.
A new study appearing in the Journal of Bone and Joint Surgery (JBJS) links the use of opioid pain relievers (prescription medications, such as Percocet) to less improvement and higher levels of dissatisfaction following spine surgery.
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
ADVENTRX Pharmaceuticals, Inc. today announced that it will meet the U.S. Food and Drug Administration in Washington D.C. during the last week of April 2010 to review the Company's New Drug Application for ANX-530 (vinorelbine injectable emulsion) and the FDA's refusal-to-file letter.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Wesley Kim, 702 S Beretania St, Suite B100, Honolulu, HI 96813-2581 Ph: (808) 538-3888 | Dr Wesley Kim, 1301 Punchbowl St, 4th Floor, Honolulu, HI 96813-2402 Ph: (808) 547-4271 |
News Archive
Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.
Centene Corporation announced today its new subsidiary, IlliniCare Health Plan, was selected by the Illinois Department of Healthcare and Family Services (HFS) as one of one of two vendors to provide managed care services to approximately 40,000 Older Adults and Adults with Disabilities in six Chicago area counties.
A new study appearing in the Journal of Bone and Joint Surgery (JBJS) links the use of opioid pain relievers (prescription medications, such as Percocet) to less improvement and higher levels of dissatisfaction following spine surgery.
NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of its first completely configured protein array kit from its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's fluorescent assays enable nanoscale detection of clinically relevant proteins.
ADVENTRX Pharmaceuticals, Inc. today announced that it will meet the U.S. Food and Drug Administration in Washington D.C. during the last week of April 2010 to review the Company's New Drug Application for ANX-530 (vinorelbine injectable emulsion) and the FDA's refusal-to-file letter.
› Verified 5 days ago
Stanley Y. Loo, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Sean Saito, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1356 Lusitana St Fl 5, Honolulu, HI 96813 Phone: 808-295-6495 | |
Dr. Christopher Lum, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, 4th Floor, Honolulu, HI 96813 Phone: 808-547-4271 | |
Janira Marita Navarro Sanchez, MD Pathology Medicare: Medicare Enrolled Practice Location: 1356 Lusitana St Fl 5, Honolulu, HI 96813 Phone: 808-586-8212 | |
Dr. Karen S Thompson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1309 Punahou St., Basement, Honolulu, HI 96826 Phone: 808-983-8581 Fax: 808-973-1401 | |
Dr. Kirk Hirata, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, 4th Floor, Honolulu, HI 96813 Phone: 808-547-4271 | |
Gregory Kiyoshi Kobayashi, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 347 N Kuakini St, Kuakini Medical Center, Honolulu, HI 96817 Phone: 808-547-9496 Fax: 808-547-9497 |